Detailed Information on Publication Record
2010
No association of FCRN promoter VNTR polymorphism with the rate of maternal-fetal IgG transfer
FREIBERGER, Tomáš, Barbora RAVČUKOVÁ, Lucie GRODECKÁ, Barbora KUŘECOVÁ, Jiří JARKOVSKÝ et. al.Basic information
Original name
No association of FCRN promoter VNTR polymorphism with the rate of maternal-fetal IgG transfer
Authors
FREIBERGER, Tomáš (203 Czech Republic, guarantor, belonging to the institution), Barbora RAVČUKOVÁ (203 Czech Republic), Lucie GRODECKÁ (203 Czech Republic), Barbora KUŘECOVÁ (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Dana BARTOŇKOVÁ (203 Czech Republic, belonging to the institution), Vojtěch THON (203 Czech Republic, belonging to the institution) and Jiří LITZMAN (203 Czech Republic, belonging to the institution)
Edition
Journal of Reproductive Immunology, Elsevier, 2010, 0165-0378
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.204
RIV identification code
RIV/00216224:14110/10:00051452
Organization unit
Faculty of Medicine
UT WoS
000279888600010
Keywords (in Czech)
Neonatální Fc receptor; FcRn; VNTR; Maternofetální transfer IgG
Keywords in English
Neonatal Fc receptor; FcRn; VNTR; Polymorphism; Maternal-fetal IgG transfer
Tags
International impact
Změněno: 10/4/2012 08:59, Mgr. Michal Petr
Abstract
V originále
The neonatal Fc receptor (FcRn) plays a critical role in maternal-fetal IgG transfer. Recently, a functionally active promoter polymorphism in the FCRN gene, represented by variable number of tandem repeats (VNTR), has been described. We analysed 103 single fetal samples and 103 paired maternal and fetal samples collected from umbilical cord blood of full-term neonates born from the 38th to the 41st week of pregnancy and detected no significant influence of maternal FCRN VNTR genotype on maternal IgG levels or of fetal FCRN VNTR genotype on fetal IgG levels or the fetal/maternal IgG ratio.